Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility
Authors:
- Joanna R. MorrisJMJoanna R. Morris
- Laurent PangonLPLaurent Pangon
- Chris BoutellCBChris Boutell
- Toyomasa KatagiriTKToyomasa Katagiri
- Nicholas H. KeepNKNicholas H. Keep
- Ellen SolomonESEllen Solomon
Open Access
- 10 January 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 15 (4) , 599-606
Abstract
The N-terminus of the Breast Cancer-1 predisposition protein (BRCA1) associates with the BRCA1-associated RING domain-1 protein (BARD1) to form a heterodimer, which exhibits ubiquitin ligase activity that is abrogated by known cancer-associated BRCA1 missense mutations. The majority of missense substitutions identified in patients with a personal or a family history of disease have not been followed in pedigrees, nor there is a functional understanding of their impact. We have examined, by extensive missense substitution, the interaction of BRCA1 with components that contribute to its ubiquitin ligase activity, BARD1 and the E2 ubiquitin-conjugating enzyme, UbcH5a. Selection from a randomly generated library of BRCA1 missense mutations for variants that inhibit the interaction with these components identified substitutions in residues found altered in patient DNA, indicating a correlation between loss of component-binding and propensity to disease development. We further show that the BRCA1:E2 interaction is sensitive to substitutions in all structural elements of the BRCA1 N-terminus, whereas the BARD1 interaction is sensitive to a subset of BRCA1 substitutions, which also inhibit E2-binding. Patient variants that inhibit the BRCA1:E2 interaction show loss of ubiquitin ligase activity and correlate with disease susceptibility and theoretical predictions of pathogenicity. These data link the loss of ubiquitin ligase activity, through loss of E2-binding, to the majority of non-polymorphic patient variants described within the N-terminus of BRCA1 and illustrate the likely significant role of BRCA1 ubiquitin ligase activity in tumour suppression.Keywords
This publication has 32 references indexed in Scilit:
- Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutralJournal of Medical Genetics, 2005
- BRCA1 and BRCA2: 1994 and beyondNature Reviews Cancer, 2004
- Analysis of missense variation in human BRCA1 in the context of interspecific sequence variationJournal of Medical Genetics, 2004
- Structure of a BRCA1–BARD1 heterodimeric RING–RING complexNature Structural & Molecular Biology, 2001
- Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1Oncogene, 2001
- Role of direct interaction in BRCA1 inhibition of estrogen receptor activityOncogene, 2001
- BRCA1 Physically and Functionally Interacts with ATF1Journal of Biological Chemistry, 2000
- CBP/p300 interact with and function as transcriptional coactivators of BRCA1Proceedings of the National Academy of Sciences, 2000
- BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppressionOncogene, 1998
- Identification of a RING protein that can interact in vivo with the BRCA1 gene productNature Genetics, 1996